Hillary Clinton Fixes Sights on Ripe Target: Prescription Drug Prices
It's a calculated risk by the front-runner, who has steered clear of other corporate targets pursued by rival Bernie Sanders.
This article is for subscribers only.
Hillary Clinton may have found the perfect target to show that she'll be as tough on corporations as her Democratic presidential rival, Bernie Sanders: Big Pharma.
Following up on her tweet last week against “price-gouging” by Turing Pharmaceuticals that sent biotech stocks plummeting, the Democratic front-runner released a hard-hitting television ad on Monday suggesting that CEO Martin Shkreli decided to lower prices after she went after him. In between, she unveiled a proposal to cap out-of-pocket drug expenses, offer tax credits to help families deal with soaring costs, force drug manufacturers to invest more on research and development, and oblige companies to invest in the production of generics.